Since its foundation in 1929 by Henri Beaufour, Ipsen has offered a wide range of products in consumer healthcare, oncology, endocrinology and neurology available to patients. Locations abroad, acquisitions, partnerships, scientific collaborations and innovations: learn about the development of our group over the years.

Early 2017: Acquisition of oncology assets of Merrimack Pharmaceuticals, a major step forward in bolstering Ipsen’s growing oncology presence and leveraging its oncology infrastructure in the United States.
Read more
Last update 17/11/2017